Page last updated: 2024-10-30

2-amino-3-phosphonopropionic acid and Eye Disorders

2-amino-3-phosphonopropionic acid has been researched along with Eye Disorders in 1 studies

2-amino-3-phosphonopropionic acid: metabotropic glutamate receptor antagonist; do not confuse AP-3 used as an abbreviation for this with enhancer-binding protein AP-3 (a trans-activator) or clathrin assembly protein AP-3
2-amino-3-phosphonopropanoic acid : A non-proteinogenc alpha-amino acid that is alanine in which one of the hydrogens of the terminal methyl group has been replaced by a dihydroxy(oxido)-lambda(5)-phosphanyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fix, AS1
Schoepp, DD1
Olney, JW1
Vestre, WA1
Griffey, KI1
Johnson, JA1
Tizzano, JP1

Other Studies

1 other study available for 2-amino-3-phosphonopropionic acid and Eye Disorders

ArticleYear
Neonatal exposure to D,L-2-amino-3-phosphonopropionate (D,L-AP3) produces lesions in the eye and optic nerve of adult rats.
    Brain research. Developmental brain research, 1993, Oct-15, Volume: 75, Issue:2

    Topics: Aging; Alanine; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Eye; Eye Diseases; Male; O

1993